HomeCompareMRCBF vs JNJ

MRCBF vs JNJ: Dividend Comparison 2026

MRCBF yields 0.69% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRCBF wins by $292.7K in total portfolio value
10 years
MRCBF
MRCBF
● Live price
0.69%
Share price
$84.54
Annual div
$0.58
5Y div CAGR
85.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$312.8K
Annual income
$195,051.89
Full MRCBF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MRCBF vs JNJ

📍 MRCBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRCBFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRCBF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MRCBF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRCBF
Annual income on $10K today (after 15% tax)
$58.69/yr
After 10yr DRIP, annual income (after tax)
$165,794.11/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MRCBF beats the other by $165,090.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRCBF + JNJ for your $10,000?

MRCBF: 50%JNJ: 50%
100% JNJ50/50100% MRCBF
Portfolio after 10yr
$166.4K
Annual income
$97,939.84/yr
Blended yield
58.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MRCBF
No analyst data
Altman Z
0.7
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRCBF buys
0
JNJ buys
0
No recent congressional trades found for MRCBF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRCBFJNJ
Forward yield0.69%3.36%
Annual dividend / share$0.58$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR85.1%5.8%
Portfolio after 10y$312.8K$20.0K
Annual income after 10y$195,051.89$827.78
Total dividends collected$282.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MRCBF vs JNJ ($10,000, DRIP)

YearMRCBF PortfolioMRCBF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,828$127.80$10,676$355.77+$152.00MRCBF
2$11,825$239.38$11,407$389.39+$418.00MRCBF
3$13,105$452.24$12,198$426.53+$907.00MRCBF
4$14,889$867.02$13,056$467.62+$1.8KMRCBF
5$17,636$1,704.08$13,987$513.12+$3.6KMRCBF
6$22,362$3,491.63$14,998$563.56+$7.4KMRCBF
7$31,586$7,658.88$16,098$619.52+$15.5KMRCBF
8$52,512$18,714.35$17,295$681.69+$35.2KMRCBF
9$110,009$53,821.42$18,599$750.82+$91.4KMRCBF
10$312,761$195,051.89$20,022$827.78+$292.7KMRCBF

MRCBF vs JNJ: Complete Analysis 2026

MRCBFStock

Morguard Corporation, a real estate investment and management corporation, acquires, owns, and develops multi-suite residential, commercial, and hotel properties in Canada and the United States. As of February 25, 2022, the company owned a portfolio of 197 multi-suite residential, retail, office, industrial, and hotel properties, including 17,752 residential suites, approximately 16.8 million square feet of commercial leasable space, and 5,058 hotel rooms. It also offers real estate management services, including acquisitions, development, dispositions, leasing, performance measurement, and asset and property management; real estate advisory services; and investment products across equity, fixed income, and balanced portfolios to institutional clients and private investors. The company is headquartered in Mississauga, Canada. Morguard Corporation is a subsidiary of Paros Enterprises Limited.

Full MRCBF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MRCBF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRCBF vs SCHDMRCBF vs JEPIMRCBF vs OMRCBF vs KOMRCBF vs MAINMRCBF vs ABBVMRCBF vs MRKMRCBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.